Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Total Debt (2020 - 2023)

Silo Pharma (SILO) has disclosed Total Debt for 4 consecutive years, with $660279.0 as the latest value for Q1 2023.

  • Quarterly Total Debt rose 918.34% to $660279.0 in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $660279.0 through Mar 2023, up 918.34% year-over-year, with the annual reading at $364216.0 for FY2022, 12.85% down from the prior year.
  • Total Debt hit $660279.0 in Q1 2023 for Silo Pharma, up from $364216.0 in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $660279.0 in Q1 2023 to a low of $3429.0 in Q1 2021.
  • Historically, Total Debt has averaged $144975.1 across 4 years, with a median of $52829.0 in 2022.
  • Biggest five-year swings in Total Debt: soared 9743.08% in 2021 and later plummeted 77.19% in 2022.
  • Year by year, Total Debt stood at $4246.0 in 2020, then skyrocketed by 9743.08% to $417937.0 in 2021, then fell by 12.85% to $364216.0 in 2022, then soared by 81.29% to $660279.0 in 2023.
  • Business Quant data shows Total Debt for SILO at $660279.0 in Q1 2023, $364216.0 in Q4 2022, and $16447.0 in Q3 2022.